Compare Medtronic PLC (MDT) vs Prospect Capital Corporation (PSEC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Prospect Capital Corporation — how do they compare? Medtronic PLC trades at $88.09 (market cap $112.24B), while Prospect Capital Corporation trades at $1.75 (market cap $974.22M). The key difference: Medtronic PLC is far larger — about 115.2× Prospect Capital Corporation's market cap, and Prospect Capital Corporation pays the higher dividend (23.01%). Which is the better fit depends on your goals — on Pluang, investors hold Medtronic PLC for 63 Days and Prospect Capital Corporation for 78 Days on average.
| MDT | PSEC | |
|---|---|---|
Market Cap | $112.24B | $974.22M |
Volume | 105,663,236 | 5,779,996 |
Sector | Health | Financials |
52-Week High | $105.35 | $3.05 |
52-Week Low | $73.75 | $1.82 |
Typical Hold Time | 63 Days | 78 Days |
Enterprise Value | $131.58B | $2.73B |
Dividend Yield | 3.28% | 23.01% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $87.80, up 2.68% today, with a bearish technical signal despite recent earnings beats. The stock shows strong fundamentals with a 13.93% net income margin and consistent dividend growth over 49 years. Revenue growth accelerated to $33.54B in 2025, and analyst consensus targets $97.80, implying 11% upside. Recent news highlights regulatory approvals for medical devices and a $4B MiniMed exchange offer.
MDT offers value with a 3.2% dividend yield and reasonable valuation (P/E 21.6), but faces headwinds from technical bearishness and rising debt. The stock's appeal hinges on execution of growth initiatives in cardiovascular and neuroscience segments, though competitive and macroeconomic risks persist.
PSEC trades at $1.80, down 2.17% today, with a bearish technical outlook showing 18 sell signals versus 5 buy signals. The company shows mixed fundamentals with a low P/B ratio of 0.33 but concerning profitability metrics including 1.01% ROE and negative revenue of -$407M for 2025. Recent earnings have consistently beaten expectations, with Q2 2026 EPS of $0.15 beating the $0.11 estimate. The stock pays a regular $0.04 monthly dividend, providing income appeal despite operational challenges.
PSEC presents a high-risk opportunity with significant challenges. The 62% NAV discount and consistent dividend payments offer value for income-focused investors, but persistent revenue volatility, negative cash flow, and bearish analyst sentiment (55% hold rating) suggest caution. Key risks include ongoing portfolio contraction and declining investment income, requiring careful monitoring of quarterly results and NAV stability for any turnaround signs.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Prospect Capital Corporation
Prospect Capital Corp is a closed-end investment company based in the United States. Its investment objective is to generate both current income and long-term capital appreciation through debt and equity investments. The company invests primarily in senior and subordinated debt and equity of private companies for acquisitions, divestitures, growth, development, recapitalizations, and other purposes. It makes investments, including lending in private equity, sponsored transactions, directly to companies, investments in structured credit, real estate, and syndicated debt.
Read more on PSEC →
